Other

OCI Cash Flow Hedge Before Reclassification and Tax

West Pharmaceutical Services OCI Cash Flow Hedge Before Reclassification and Tax increased by 35.3% to -$1.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 164.7%, from $1.70M to -$1.10M.

Analysis

StatementIncome Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ3 2023
Last reportedQ1 2026Apr 23, 2026

How to read this metric

Changes indicate the effectiveness and market value movement of the firm's hedging portfolio against underlying risk exposures.

Detailed definition

This reflects the unrealized gains or losses on derivative instruments designated as cash flow hedges before they are re...

Peer comparison

Common in firms with significant derivative hedging programs.

Metric ID: ibm_oci_cash_flow_hedge_before_reclassification_and_tax

Historical Data

8 periods
 Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value-$2.00M-$2.80M-$3.70M$5.50M$1.70M$2.20M-$1.70M-$1.10M
QoQ Change-40.0%-32.1%+248.6%-69.1%+29.4%-177.3%+35.3%
YoY Change+375.0%+160.7%+159.5%-130.9%-164.7%
Range-$3.70M$5.50M
CAGR-28.9%
Avg YoY Growth+79.9%
Median YoY Growth+159.5%

OCI Cash Flow Hedge Before Reclassification and Tax at Other Companies

Frequently Asked Questions

What is West Pharmaceutical Services's oci cash flow hedge before reclassification and tax?
West Pharmaceutical Services (WST) reported oci cash flow hedge before reclassification and tax of -$1.10M in Q1 2026.
How has West Pharmaceutical Services's oci cash flow hedge before reclassification and tax changed year-over-year?
West Pharmaceutical Services's oci cash flow hedge before reclassification and tax decreased by 164.7% year-over-year, from $1.70M to -$1.10M.
What does oci cash flow hedge before reclassification and tax mean?
Unrealized gains or losses on cash flow hedges before tax and reclassification.